IBDEI3AM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,55338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55338,1,3,0)
 ;;=3^Alcoholic Hepatic Failure w/ Coma
 ;;^UTILITY(U,$J,358.3,55338,1,4,0)
 ;;=4^K70.41
 ;;^UTILITY(U,$J,358.3,55338,2)
 ;;=^5008791
 ;;^UTILITY(U,$J,358.3,55339,0)
 ;;=K73.0^^256^2778^15
 ;;^UTILITY(U,$J,358.3,55339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55339,1,3,0)
 ;;=3^Hepatitis, Chronic Persistent NEC
 ;;^UTILITY(U,$J,358.3,55339,1,4,0)
 ;;=4^K73.0
 ;;^UTILITY(U,$J,358.3,55339,2)
 ;;=^5008811
 ;;^UTILITY(U,$J,358.3,55340,0)
 ;;=K74.0^^256^2778^14
 ;;^UTILITY(U,$J,358.3,55340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55340,1,3,0)
 ;;=3^Hepatic Fibrosis
 ;;^UTILITY(U,$J,358.3,55340,1,4,0)
 ;;=4^K74.0
 ;;^UTILITY(U,$J,358.3,55340,2)
 ;;=^5008816
 ;;^UTILITY(U,$J,358.3,55341,0)
 ;;=K74.69^^256^2778^10
 ;;^UTILITY(U,$J,358.3,55341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55341,1,3,0)
 ;;=3^Cirrhosis of Liver,Oth
 ;;^UTILITY(U,$J,358.3,55341,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,55341,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,55342,0)
 ;;=K74.60^^256^2778^11
 ;;^UTILITY(U,$J,358.3,55342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55342,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,55342,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,55342,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,55343,0)
 ;;=K76.0^^256^2778^12
 ;;^UTILITY(U,$J,358.3,55343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55343,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,55343,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,55343,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,55344,0)
 ;;=K76.89^^256^2778^18
 ;;^UTILITY(U,$J,358.3,55344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55344,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,55344,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,55344,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,55345,0)
 ;;=K71.6^^256^2778^32
 ;;^UTILITY(U,$J,358.3,55345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55345,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,55345,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,55345,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,55346,0)
 ;;=K75.9^^256^2778^17
 ;;^UTILITY(U,$J,358.3,55346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55346,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,55346,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,55346,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,55347,0)
 ;;=K71.0^^256^2778^24
 ;;^UTILITY(U,$J,358.3,55347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55347,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,55347,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,55347,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,55348,0)
 ;;=K71.10^^256^2778^30
 ;;^UTILITY(U,$J,358.3,55348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55348,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,55348,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,55348,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,55349,0)
 ;;=K71.11^^256^2778^31
 ;;^UTILITY(U,$J,358.3,55349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55349,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,55349,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,55349,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,55350,0)
 ;;=K71.2^^256^2778^23
 ;;^UTILITY(U,$J,358.3,55350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55350,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,55350,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,55350,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,55351,0)
 ;;=K71.3^^256^2778^28
